Max Robotics — Global Service Robot Directory + US Certification

About

Diana Mehedint is a urologic surgeon and researcher whose work focuses on advancing minimally invasive surgical techniques for kidney, bladder, and prostate cancers. Her most impactful contributions center on defining learning curves and improving outcomes for robot-assisted surgeries. Her landmark study on "Learning Curves for Robot-Assisted and Laparoscopic Partial Nephrectomy" (89 citations) provided critical benchmarks for surgical proficiency, helping institutions optimize training for these complex procedures. She has also made significant contributions to understanding postoperative outcomes, including her work on readmission predictors after robot-assisted radical cystectomy (50 citations) and health-related quality of life following bladder cancer surgery (42 citations). Mehedint's research on low detectable PSA after radical prostatectomy (17 citations) offered valuable guidance for clinical decision-making in prostate cancer surveillance. Additionally, she externally validated prognostic nomograms for bladder cancer (17 citations), enhancing predictive accuracy for clinicians. Her work has been instrumental in establishing evidence-based practices for robot-assisted urologic oncology, directly impacting surgical training, patient counseling, and postoperative management strategies.